CAMBRIDGE, Mass. (AP) _ Epizyme Inc. (EPZM) on Friday reported a loss of $37.5 million in its third quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 54 cents.
The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 60 cents per share.
Epizyme shares have dropped 33 percent since the beginning of the year. The stock has fallen 48 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EPZM at https://www.zacks.com/ap/EPZM